Understanding EndoBarrier Therapy, a breakthrough in Type 2 Diabetes
Clinical data suggest that EndoBarrier Therapy works by affecting key hormones involved in insulin sensitivity, glucose metabolism, satiety and food intake.1,2. Such result can allow for a reduction in oral diabetes medications and may prevent a progression to insulin.
1. deJonge C, et al, “The impact of the EndoBarrier on body weight and satiety hormones.” Poster presented at UEGW 2013, Amsterdam, The Netherlands. 2. Moura, GHD, et al., ‘One Year Results of an Endoscopic, Duodenal-Jejunal Exclusion Device for Weight Loss and Control of Type 2 Diabetes.’, DT&T, February 2012, vol 14, no.2:183-189. Slides: 1. Segal-Leiberman G., et al, ‘The Acute Effect of EndoBarrier Treatment on Glucose Homeostasis in Obese Uncontrolled Diabetic Subjects’. Poster presented at ADA June 7 2014. 2. GI Dynamics, Data on file.